[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": 783745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arundathy Nirmalini Pandite M.B.A., M.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 678764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.13, "open": 9.395, "dayLow": 8.91, "dayHigh": 9.395, "regularMarketPreviousClose": 9.13, "regularMarketOpen": 9.395, "regularMarketDayLow": 8.91, "regularMarketDayHigh": 9.395, "beta": 2.135, "forwardPE": -4.8586955, "volume": 319861, "regularMarketVolume": 319861, "averageVolume": 1863658, "averageVolume10days": 443330, "averageDailyVolume10Day": 443330, "bid": 8.77, "ask": 13.0, "bidSize": 1000, "askSize": 800, "marketCap": 424424704, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.11, "priceToSalesTrailing12Months": 256.14044, "fiftyDayAverage": 9.1272, "twoHundredDayAverage": 4.17621, "currency": "USD", "enterpriseValue": 298001568, "floatShares": 30254255, "sharesOutstanding": 47474800, "sharesShort": 1415705, "sharesShortPriorMonth": 749343, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0298, "heldPercentInsiders": 0.13259, "heldPercentInstitutions": 0.59874, "shortRatio": 4.53, "shortPercentOfFloat": 0.0438, "bookValue": 3.062, "priceToBook": 2.91966, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -87298000, "trailingEps": -2.05, "forwardEps": -1.84, "enterpriseToRevenue": 179.844, "enterpriseToEbitda": -3.401, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.94, "targetHighPrice": 28.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.5, "targetMedianPrice": 12.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 130625000, "totalCashPerShare": 2.751, "ebitda": -87615000, "totalDebt": 4202000, "quickRatio": 11.405, "currentRatio": 12.505, "totalRevenue": 1657000, "debtToEquity": 2.904, "revenuePerShare": 0.039, "returnOnAssets": -0.31399, "returnOnEquity": -0.54415, "freeCashflow": -49609624, "operatingCashflow": -81228000, "revenueGrowth": 0.831, "operatingMargins": -26.121851, "financialCurrency": "USD", "trailingPegRatio": null}]